ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · IEX Real-Time Price · USD
-0.030 (-1.68%)
At close: Jun 14, 2024, 4:00 PM
+0.060 (3.41%)
After-hours: Jun 14, 2024, 4:11 PM EDT

ProQR Therapeutics Statistics

Total Valuation

PRQR has a market cap or net worth of $143.73 million. The enterprise value is $54.21 million.

Market Cap 143.73M
Enterprise Value 54.21M

Important Dates

The next estimated earnings date is Thursday, August 1, 2024, before market open.

Earnings Date Aug 1, 2024
Ex-Dividend Date n/a

Share Statistics

PRQR has 81.66 million shares outstanding.

Shares Outstanding 81.66M
Owned by Insiders (%) 18.87%
Owned by Institutions (%) 39.05%
Float 57.80M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 9.80
Forward PS n/a
PB Ratio 3.85
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.70
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.55.

Current Ratio 3.11
Quick Ratio 3.10
Debt / Equity 0.55
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -62.19

Financial Efficiency

Return on equity (ROE) is -61.60% and return on invested capital (ROIC) is -56.52%.

Return on Equity (ROE) -61.60%
Return on Assets (ROA) -19.50%
Return on Capital (ROIC) -56.52%
Revenue Per Employee $93,980
Profits Per Employee -$187,040
Employee Count 156
Asset Turnover 0.10
Inventory Turnover n/a


Income Tax -80,420
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +5.92% in the last 52 weeks. The beta is 0.34, so PRQR's price volatility has been lower than the market average.

Beta (1Y) 0.34
52-Week Price Change +5.92%
50-Day Moving Average 1.98
200-Day Moving Average 1.84
Relative Strength Index (RSI) 36.47
Average Volume (30 Days) 130,209

Short Selling Information

Short Interest 241,218
Short Previous Month 232,490
Short % of Shares Out 0.40%
Short % of Float n/a
Short Ratio (days to cover) 1.61

Income Statement

In the last 12 months, PRQR had revenue of $14.66 million and -$29.18 million in losses. Loss per share was -$0.35.

Revenue 14.66M
Gross Profit 14.46M
Operating Income -32.75M
Pretax Income -28.86M
Net Income -29.18M
EBITDA -25.56M
EBIT -28.41M
Loss Per Share -$0.35
Full Income Statement

Balance Sheet

The company has $110.14 million in cash and $20.62 million in debt, giving a net cash position of $89.52 million or $1.10 per share.

Cash & Cash Equivalents 110.14M
Total Debt 20.62M
Net Cash 89.52M
Net Cash Per Share $1.10
Equity / Book Value 37.34M
Book Value Per Share 0.46
Working Capital 77.99M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$41.68 million and capital expenditures $6.42 million, giving a free cash flow of -$35.26 million.

Operating Cash Flow -41.68M
Capital Expenditures 6.42M
Free Cash Flow -35.26M
FCF Per Share -$0.43
Full Cash Flow Statement


Gross margin is 98.65%, with operating and profit margins of -223.40% and -199.02%.

Gross Margin 98.65%
Operating Margin -223.40%
Pretax Margin -196.88%
Profit Margin -199.02%
EBITDA Margin -174.35%
EBIT Margin -193.76%
FCF Margin -240.50%

Dividends & Yields

PRQR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.84%
Shareholder Yield -0.84%
Earnings Yield -20.30%
FCF Yield -24.53%

Analyst Forecast

The average price target for PRQR is $3.38, which is 92.05% higher than the current price. The consensus rating is "Strong Buy".

Price Target $3.38
Price Target Difference 92.05%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 38.43%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Altman Z-Score n/a
Piotroski F-Score 3